Founder of 335, Inc., Joshua R. Lamstein currently occupies the position of Chairman at Scopus Biopharma, Inc., Managing Director at HCFP LLC and Partner at KEC Ventures. Mr. Lamstein is also on the board of 5 other companies.

In the past Mr. Lamstein occupied the position of Chief Operating Officer at 335, Inc., Chief Financial Officer for John Snow, Inc., General Partner for Briefcam Investments LP, General Partner at Isoseles Madefire Investors LLC, Co-Chairman of GSP Nutrition, Inc., Associate at Lehman Brothers, Inc., Associate of Apollo Advisors LP, Partner at LMS Capital Plc, Managing Director at GF Capital Private Equity Management LLC and Associate for Lehman Brothers Ltd.

He received an undergraduate degree from Colgate University and a graduate degree from MIT Sloan School of Management.